SVB Wealth LLC Purchases 1,358 Shares of HCA Healthcare, Inc. (NYSE:HCA)

SVB Wealth LLC boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 48.1% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,183 shares of the company’s stock after acquiring an additional 1,358 shares during the quarter. SVB Wealth LLC’s holdings in HCA Healthcare were worth $1,395,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the stock. Realta Investment Advisors raised its stake in shares of HCA Healthcare by 8.5% during the fourth quarter. Realta Investment Advisors now owns 2,067 shares of the company’s stock valued at $560,000 after acquiring an additional 162 shares in the last quarter. PFG Advisors lifted its holdings in shares of HCA Healthcare by 12.9% in the 4th quarter. PFG Advisors now owns 1,357 shares of the company’s stock worth $367,000 after buying an additional 155 shares during the period. Denali Advisors LLC lifted its holdings in shares of HCA Healthcare by 5.0% in the 4th quarter. Denali Advisors LLC now owns 2,100 shares of the company’s stock worth $568,000 after buying an additional 100 shares during the period. Wolf Group Capital Advisors lifted its stake in shares of HCA Healthcare by 4.7% during the 4th quarter. Wolf Group Capital Advisors now owns 8,592 shares of the company’s stock worth $2,326,000 after purchasing an additional 384 shares during the last quarter. Finally, First Citizens Bank & Trust Co. bought a new position in HCA Healthcare in the fourth quarter worth about $3,132,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Up 1.3 %

HCA stock traded up $4.75 during midday trading on Tuesday, hitting $363.48. The company’s stock had a trading volume of 121,103 shares, compared to its average volume of 1,153,009. The firm has a 50-day simple moving average of $330.79 and a 200-day simple moving average of $323.36. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $363.66. The firm has a market capitalization of $95.20 billion, a P/E ratio of 17.88, a PEG ratio of 1.36 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $4.29 earnings per share. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 22.43 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be given a dividend of $0.66 per share. The ex-dividend date is Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.73%. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Insider Activity at HCA Healthcare

In other news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares in the company, valued at $14,569,729.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The disclosure for this sale can be found here. Insiders have sold 18,254 shares of company stock valued at $6,022,057 in the last ninety days. Insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Truist Financial increased their target price on shares of HCA Healthcare from $375.00 to $390.00 and gave the company a “buy” rating in a research report on Wednesday, July 24th. TD Cowen lowered their target price on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research note on Tuesday, April 30th. Robert W. Baird assumed coverage on HCA Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $396.00 price target on the stock. SVB Leerink lifted their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Finally, JPMorgan Chase & Co. boosted their price objective on HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a report on Thursday, May 30th. Four investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $344.06.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.